Work

CS1-Specific Chimeric Antigen Receptor (CAR)-Engineered NK Cells and T Cells Enhance In Vitro and In Vivo Anti-Tumor Activity Against Human Multiple Myeloma

Year: 2013

Type: article

Source: Blood

DOI: 10.1182/blood.v122.21.14.14

Authors: Jianhong Chu, Youcai Deng, Don M. Benson, Shun He, Tiffany L. Hughes, Jianying Zhang, Yong Peng, Hsiaoyin Mao, Ling Yi, Kalpana Ghoshal, Xiaoming He, Steven M. Devine, Xiaoliu Zhang, Michael A. Caligiuri, Craig C. Hofmeister, Jianhua Yu

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, University of Houston

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W61403512

FWCI: 0.178

Cites: 56

Cited by: 2

Related to: 10